Group A (n = 140) | Group B (n = 329) | Group C (n = 431) | p value | |
---|---|---|---|---|
Antiarrhythmics | 11 (7.9) | 23 (7.0) | 63 (14.6) | 0.002 |
β blockers | 79 (56.4) | 160 (48.6) | 136 (31.6) | < 0.001 |
Aspirin | 134 (95.7) | 320 (97.3) | 315 (73.1) | < 0.001 |
ACE inhibitors | 13 (9.3) | 20 (6.1) | 72 (16.7) | < 0.001 |
Anticoagulants (heparin, warfarin) | 122 (87.1) | 223 (67.8) | 171 (39.7) | < 0.001 |
Diuretics | 47 (33.6) | 134 (40.7) | 250 (58.0) | < 0.001 |
Digoxin | 12 (8.6) | 31 (9.4) | 92 (21.3) | < 0.001 |
Values are numbers of patients receiving treatment (%).